Cargando…

Application of an optimized flow cytometry-based quantification of Platelet Activation (PACT): Monitoring platelet activation in platelet concentrates

BACKGROUND: Previous studies have shown that flow cytometry is a reliable test to quantify platelet function in stored platelet concentrates (PC). It is thought that flow cytometry is laborious and hence expensive. We have optimized the flow cytometry-based quantification of agonist induced platelet...

Descripción completa

Detalles Bibliográficos
Autores principales: Kicken, Cécile H., Roest, Mark, Henskens, Yvonne M. C., de Laat, Bas, Huskens, Dana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5313179/
https://www.ncbi.nlm.nih.gov/pubmed/28207883
http://dx.doi.org/10.1371/journal.pone.0172265
_version_ 1782508313741623296
author Kicken, Cécile H.
Roest, Mark
Henskens, Yvonne M. C.
de Laat, Bas
Huskens, Dana
author_facet Kicken, Cécile H.
Roest, Mark
Henskens, Yvonne M. C.
de Laat, Bas
Huskens, Dana
author_sort Kicken, Cécile H.
collection PubMed
description BACKGROUND: Previous studies have shown that flow cytometry is a reliable test to quantify platelet function in stored platelet concentrates (PC). It is thought that flow cytometry is laborious and hence expensive. We have optimized the flow cytometry-based quantification of agonist induced platelet activation (PACT) to a labor, time and more cost-efficient test. Currently the quality of PCs is only monitored by visual inspection, because available assays are unreliable or too laborious for use in a clinical transfusion laboratory. Therefore, the PACT was applied to monitor PC activation during storage. STUDY DESIGN AND METHODS: The optimized PACT was used to monitor 5 PCs during 10 days of storage. In brief, optimized PACT uses a ready-to-use reaction mix, which is stable at -20°C. When needed, a test strip is thawed and platelet activation is initiated by mixing PC with PACT. PACT was based on the following agonists: adenosine diphosphate (ADP), collagen-related peptide (CRP) and thrombin receptor-activating peptide (TRAP-6). Platelet activation was measured as P-selectin expression. Light transmission aggregometry (LTA) was performed as a reference. RESULTS: Both PACT and LTA showed platelet function decline during 10-day storage after stimulation with ADP and collagen/CRP; furthermore, PACT showed decreasing TRAP-induced activation. Major differences between the two tests are that PACT is able to measure the status of platelets in the absence of agonists, and it can differentiate between the number of activated platelets and the amount of activation, whereas LTA only measures aggregation in response to an agonist. Also, PACT is more time-efficient compared to LTA and allows high-throughput analysis. CONCLUSION: PACT is an optimized platelet function test that can be used to monitor the activation of PCs. PACT has the same accuracy as LTA with regard to monitoring PCs, but it is superior to both LTA and conventional flow cytometry based tests with regard to labor-, time- and cost efficiency.
format Online
Article
Text
id pubmed-5313179
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-53131792017-03-03 Application of an optimized flow cytometry-based quantification of Platelet Activation (PACT): Monitoring platelet activation in platelet concentrates Kicken, Cécile H. Roest, Mark Henskens, Yvonne M. C. de Laat, Bas Huskens, Dana PLoS One Research Article BACKGROUND: Previous studies have shown that flow cytometry is a reliable test to quantify platelet function in stored platelet concentrates (PC). It is thought that flow cytometry is laborious and hence expensive. We have optimized the flow cytometry-based quantification of agonist induced platelet activation (PACT) to a labor, time and more cost-efficient test. Currently the quality of PCs is only monitored by visual inspection, because available assays are unreliable or too laborious for use in a clinical transfusion laboratory. Therefore, the PACT was applied to monitor PC activation during storage. STUDY DESIGN AND METHODS: The optimized PACT was used to monitor 5 PCs during 10 days of storage. In brief, optimized PACT uses a ready-to-use reaction mix, which is stable at -20°C. When needed, a test strip is thawed and platelet activation is initiated by mixing PC with PACT. PACT was based on the following agonists: adenosine diphosphate (ADP), collagen-related peptide (CRP) and thrombin receptor-activating peptide (TRAP-6). Platelet activation was measured as P-selectin expression. Light transmission aggregometry (LTA) was performed as a reference. RESULTS: Both PACT and LTA showed platelet function decline during 10-day storage after stimulation with ADP and collagen/CRP; furthermore, PACT showed decreasing TRAP-induced activation. Major differences between the two tests are that PACT is able to measure the status of platelets in the absence of agonists, and it can differentiate between the number of activated platelets and the amount of activation, whereas LTA only measures aggregation in response to an agonist. Also, PACT is more time-efficient compared to LTA and allows high-throughput analysis. CONCLUSION: PACT is an optimized platelet function test that can be used to monitor the activation of PCs. PACT has the same accuracy as LTA with regard to monitoring PCs, but it is superior to both LTA and conventional flow cytometry based tests with regard to labor-, time- and cost efficiency. Public Library of Science 2017-02-16 /pmc/articles/PMC5313179/ /pubmed/28207883 http://dx.doi.org/10.1371/journal.pone.0172265 Text en © 2017 Kicken et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Kicken, Cécile H.
Roest, Mark
Henskens, Yvonne M. C.
de Laat, Bas
Huskens, Dana
Application of an optimized flow cytometry-based quantification of Platelet Activation (PACT): Monitoring platelet activation in platelet concentrates
title Application of an optimized flow cytometry-based quantification of Platelet Activation (PACT): Monitoring platelet activation in platelet concentrates
title_full Application of an optimized flow cytometry-based quantification of Platelet Activation (PACT): Monitoring platelet activation in platelet concentrates
title_fullStr Application of an optimized flow cytometry-based quantification of Platelet Activation (PACT): Monitoring platelet activation in platelet concentrates
title_full_unstemmed Application of an optimized flow cytometry-based quantification of Platelet Activation (PACT): Monitoring platelet activation in platelet concentrates
title_short Application of an optimized flow cytometry-based quantification of Platelet Activation (PACT): Monitoring platelet activation in platelet concentrates
title_sort application of an optimized flow cytometry-based quantification of platelet activation (pact): monitoring platelet activation in platelet concentrates
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5313179/
https://www.ncbi.nlm.nih.gov/pubmed/28207883
http://dx.doi.org/10.1371/journal.pone.0172265
work_keys_str_mv AT kickencecileh applicationofanoptimizedflowcytometrybasedquantificationofplateletactivationpactmonitoringplateletactivationinplateletconcentrates
AT roestmark applicationofanoptimizedflowcytometrybasedquantificationofplateletactivationpactmonitoringplateletactivationinplateletconcentrates
AT henskensyvonnemc applicationofanoptimizedflowcytometrybasedquantificationofplateletactivationpactmonitoringplateletactivationinplateletconcentrates
AT delaatbas applicationofanoptimizedflowcytometrybasedquantificationofplateletactivationpactmonitoringplateletactivationinplateletconcentrates
AT huskensdana applicationofanoptimizedflowcytometrybasedquantificationofplateletactivationpactmonitoringplateletactivationinplateletconcentrates